Programming Cells at Ginkgo Bioworks, COVID, and the Future of Biosecurity

44:09
 
Share
 

Manage episode 301061065 series 2605263
By Jim O'Brien. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Matthew McKnight is the Chief Commercial Officer of Ginkgo Bioworks. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. The company’s cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.

Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery.

Prior to Ginkgo, Matt spent 7 years as an investor at IndUS Growth Partners and was the President and COO of Decision Resources Group. Matt has worked supporting business development at Palantir Technologies and is an active seed stage venture investor.

Early in his career, he served as an officer in the United States Marine Corps. Matt completed a degree in History at Dartmouth College and is a graduate of the joint degree program at the Harvard Business School and the Harvard Kennedy School of Government where he was a Zuckerman Fellow.

  • Check out one of Matthew and Jim's favorite blogs - Wait But Why.

Help us grow! Leave us a rating and review - it's the best way to bring new listeners to the show. Don't forget to subscribe!

Have a suggestion, or want to chat with Jim? Email him at Jim@ThePoliticalLife.net

Follow The Political Life on Facebook, Instagram, LinkedIn and Twitter for weekly updates.

175 episodes